OCMS Bio provides discovery and engineering tools and services for the monoclonal antibody industry. Our proprietary On Cell mAb Screening technology allows us to evaluate millions of antibodies expressed in mammalian cells at a fraction of the time and cost of traditional methods. By delivering data on binding and expression levels for every antibody we screen, we enable our partners to discover and optimize “one in a million” antibodies.